Skip to content
2000
Volume 26, Issue 25
  • ISSN: 0929-8673
  • E-ISSN: 1875-533X

Abstract

P-glycoprotein, also known as ABCB1 in the ABC transporter family, confers the simultaneous resistance of metastatic cancer cells towards various anticancer drugs with different targets and diverse chemical structures. The exploration of safe and specific inhibitors of this pump has always been the pursuit of scientists for the past four decades. Naturally occurring flavonoids as benzopyrone derivatives were recognized as a class of nontoxic inhibitors of P-gp. The recent advent of synthetic flavonoid dimer FD18, as a potent P-gp modulator in reversing multidrug resistance both in vitro and in vivo, specifically targeted the pseudodimeric structure of the drug transporter and represented a new generation of inhibitors with high transporter binding affinity and low toxicity. This review concerned the recent updates on the structure-activity relationships of flavonoids as P-gp inhibitors, the molecular mechanisms of their action and their ability to overcome P-gp-mediated MDR in preclinical studies. It had crucial implications on the discovery of new drug candidates that modulated the efflux of ABC transporters and also provided some clues for the future development in this promising area.

Loading

Article metrics loading...

/content/journals/cmc/10.2174/0929867325666181001115225
2019-08-01
2025-05-09
Loading full text...

Full text loading...

/content/journals/cmc/10.2174/0929867325666181001115225
Loading

  • Article Type:
    Review Article
Keyword(s): anticancer; flavonoids; inhibitors; multidrug resistance; P-glycoprotein; SARs
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test